Susan Horvath
2019
In 2019, Susan Horvath earned a total compensation of $401.4K as Chief Financial Officer and Vice President of Finance at Panbela Therapeutics.
Compensation breakdown
Option Awards | $181,124 |
---|---|
Salary | $220,313 |
Total | $401,436 |
Horvath received $220.3K in salary, accounting for 55% of the total pay in 2019.
Horvath also received $181.1K in option awards.
Rankings
In 2019, Susan Horvath's compensation ranked 12,331st out of 13,971 executives tracked by ExecPay. In other words, Horvath earned more than 11.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 12,331 | 12th |
Manufacturing | 4,994 | 12th |
Chemicals And Allied Products | 1,966 | 11th |
Drugs | 1,692 | 10th |
Pharmaceutical Preparations | 1,253 | 10th |
Horvath's colleagues
We found one more compensation record of an executive who worked with Susan Horvath at Panbela Therapeutics in 2019.
2019
Michael Cullen
Panbela Therapeutics